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Vibrio cholerae is a human diarrhoeal pathogen that is a major cause of gastrointestinal disease
and death worldwide. Pathogenic V. cholerae strains are characterized by the presence of a Vibrio
pathogenicity island (VPI) that encodes virulence factors, including the toxin co-regulated pilus
(TCP). TagA is encoded within the VPI and is positively co-regulated with cholera toxin and TCP.
TagA is a sequelogue of the StcE mucinase of Escherichia coli O157:H7. We investigated
whether this sequence homology reflected a conserved enzymic substrate profile. TagA exhibited
metalloprotease activity toward crude purified mucins, salivary mucin and LS174T goblet cell
surface mucin. Like StcE, TagA did not cleave general protease substrates, but unlike StcE, TagA
did not cleave the mucin-like serpin C1 esterase inhibitor. Both proteins cleaved the immune cell
surface mucin CD43, but TagA demonstrated reduced enzymic efficiency relative to StcE. TagA
was expressed and secreted by V. cholerae under ToxR-dependent conditions. A tagA-deficient
V. cholerae strain showed no defect in a model of in vitro attachment to the HEp-2 cell line;
however, overexpression of a proteolytically inactive mutant, TagA(E433D), caused a significant
increase in attachment. The increased attachment was reduced by pretreatment of epithelial
monolayers with active TagA. Our results indicate that TagA is a mucinase and suggest that TagA
may directly modify host cell surface molecules during V. cholerae infection.
INTRODUCTION
The Gram-negative bacterium Vibrio cholerae causes a
secretory diarrhoeal disease in humans that has been the
cause of at least seven worldwide pandemics since the 19th
century (Sack et al., 2004). Both pathogenic and non-
pathogenic V. cholerae are found in the environment, and
the vast majority of disease is caused by V. cholerae of the
O1 serotype. Disease-causing strains of V. cholerae possess
two distinct pathogenic elements, the Vibrio pathogenicity
island (VPI) and the cholera toxin phage (ctxW) (Kaper
et al., 1995). The VPI is a 40 kb pathogenicity island that
encodes several potential virulence factors and the toxin
co-regulated pilus (TCP) (Karaolis et al., 1998, 2001). TCP
is a type IV pilus that is required for colonization of the
human intestine (Herrington et al., 1988; Taylor et al.,
1987). Cholera toxin (CT) is transcriptionally co-regulated
with TCP by the ToxR/S/T regulon, which activates
numerous genes of the VPI (Champion et al., 1997;
Matson et al., 2007). CT is the major cause of secretory
diarrhoea induced by V. cholerae and can recapitulate
disease when given alone (Levine et al., 1983). However,
vaccine strains lacking CT can cause diarrhoea in human
volunteers, suggesting that other virulence factors, includ-
ing some VPI genes, may play a role in disease (Silva et al.,
1996; Harrison et al., 2008; Rui et al., 2010).
One potential VPI-encoded virulence factor is TagA
(ToxR-activated gene A), a homologue of the StcE
mucinase of enterohaemorrhagic E. coli (EHEC). The
small intestinal niche of V. cholerae is coated with a
protective layer of thick mucus to which the bacteria
preferentially adhere (Yamamoto et al., 1988). Mucinase
activity of V. cholerae was first described over 50 years ago
as a complex with both neuraminidase and protease
activities that were eventually attributed to the 32 kDa
haemagglutinin/protease (HA/P) (Finkelstein et al., 1983;
Stewart-Tull et al., 1986; Burnet, 1949; Schneider & Parker,
1982). HA/P is an elastase-like general metalloprotease that
cleaves a wide variety of substrates, including ovomucin,
BSA, casein, elastin and CT (Finkelstein et al., 1983; Ha ¨se &
Finkelstein, 1990; Booth et al., 1983, 1984). Although HA/P
promotes mucin gel penetration (Silva et al., 2003), it is not
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1992; Ha ¨se & Finkelstein, 1991). Rather, it provides
detachase activity that may allow bacteria to disengage
from the intestinal epithelium and disseminate (Finkelstein
et al., 1992). Expression profiling suggests that HA/P is
active late in infection and regulated oppositely to
virulence genes (Zhu et al., 2002). Penetration of the
mucus layer is presumably important during initial
colonization, and a role for a specific mucinase early in
infection remains to be described.
TagA is encoded by the VPI and is part of the ToxR/S/T
regulon (Withey & Dirita, 2005). Microarray analysis of
stool samples from patients with cholera detected tagA
transcript, suggesting that it is expressed during infection
(Bina et al., 2003). TagA is a putative 115 kDa secreted
lipoprotein that is homologous to StcE (Secreted protease
of C1 esterase inhibitor), a metalloprotease secreted by
E. coli O157:H7. StcE is the prototypic member of the
SLiMe (StcE-like metalloprotease) family, a group of large
proteins of Gram-negative bacteria that share a consensus
protease domain with a conserved zinc metalloprotease
active site. StcE cleaves specific mucin-type O-glycosylated
proteins, including C1 esterase inhibitor (C1-INH), CD43
and mucin 7 (MUC7), and increases the ability of E. coli
O157:H7 to intimately adhere to epithelial cells (Grys et al.,
2005; Lathem et al., 2002; Szabady et al., 2009). The StcE
homologue of Aeromonas hydrophila contributes to
virulence in a mouse peritonitis model (Pillai et al.,
2006), and evidence suggests that StcE may be involved in
colonization of the rabbit intestine by EHEC (Ho et al.,
2008). Here we investigate the hypothesis that TagA,
similar to StcE, is a secreted mucinase and contributes to
colonization of the intestinal epithelium.
METHODS
Bacterial strains and plasmids. Bacterial strains were maintained
in LB medium with 50% glycerol at 280 uC. Bacteria were grown
under ToxR-inducing conditions at 30 uC in LB medium pH 6.5
(Miller & Mekalanos, 1988). Ampicillin was used at 100 mgm l
–1. V.
cholerae O1 El tor strain N16961 was obtained from ATCC
(Manassas, VA, USA). Classical biotype V. cholerae O395 Sm
R and
JJM43 (V. cholerae O395 Sm
R toxR43) were kind gifts from R. K.
Taylor (Dartmouth College, Hanover, NH, USA). MC4100 lpir
containing pKAS32 was a kind gift from V. J. DiRita (University of
Michigan, Ann Arbor, MI, USA).
A tagA deletion in V. cholerae O395 Sm
R was constructed using allelic
exchange as described by Skorupski & Taylor (1996). Briefly, DNA
flanking tagA was PCR amplified from the VPI (GenBank accession
no. AF325733) using the oligos A (59-CGGGTACCCGGAAGCA-
GCACCTTCTTGTG-39) and B (59-CCACAGTCATCAAAAAAAGT-
TCTATAGTTTAACTCCTCGTAAACATTTTTCGA-39) for nt 3355–
3988, and oligos C (59-TCGAAAAATGTTTACGAGGAGTTAAACT-
ATAGAACTTTTTTTGATGACTGTGG-39) and D (59-CGGAGCTC-
GGAATCGCTGTATGCAGGTATC-39) for nt 6998–8093, using
genomic DNA as template and TripleMaster DNA polymerase
(Eppendorf). The resultant PCR fragments were then ligated by
PCR with primers A and D. The resultant product was ligated into
pKAS32, an R6K suicide vector that expresses rpsL (Skorupski &
Taylor, 1996), transformed into CC118 lpir (Herrero et al., 1990) and
mated into V. cholerae O395 Sm
R. Transconjugants were isolated on
TCBS agar with 250 mg carbenicillin ml
–1, recovered on LB agar and
counterselected on LB agar with 1 mg streptomycin ml
–1. Deletion of
tagA (DtagA) was confirmed by PCR.
pBAD24 A
R (Guzman et al., 1995) was a gift from Charles Cowles
(University of Wisconsin, Madison, WI, USA). The entire tagA gene,
including the signal sequence, was PCR-amplified from V. cholerae
O1 genomic DNA using oligos E (59-CGGGCTAGCTACGAGGA-
GTTAGTGGTGG-39) and F (59-GCGGCATGCTCTATAGTTTTA-
ATGGTAGGTCATCG-39) and cloned into pBAD24 using NheI and
SphI (NEB) to create pTagA. The proteolytically inactive
TagA(E433D) mutant was created by PCR mutagenesis using primer
G( 5 9-CGAATGGTCTCATGATTTGGGACATAACTATGGATTGG-
GAC-39) and its complementary oligonucleotide to create pE433D.
pTagA and pE433D were confirmed by DNA sequencing. As a control
for attachment experiments, pBAD24 was transformed into V.
cholerae O395 wt and DtagA.
For analysis of TagA expression, V. cholerae O395 wt, DtagA or the
toxR null mutant (JJM43) were grown under ToxR-inducing
conditions overnight (Taylor et al., 1987). Cells were pelleted and
proteins in culture supernatants were precipitated with 10%
trichloroacetic acid on ice. Samples were separated by SDS-PAGE
and transferred to nitrocellulose. Protein expression was detected
with polyclonal antiserum to a TagA peptide (aa 44–57,
KKPSRPIIDEKNKG) raised in rabbits (Open Biosystems) and used
at 1:2000 dilution.
Protein purification. pTagA and pE433D were transformed into V.
cholerae O395 DtagA. Bacteria were grown to mid-exponential phase
in LB (pH 6.5) with ampicillin, and protein expression was induced
with 0.1% arabinose for 24 h at 30 uC. Culture supernatants were
filtered and precipitated with ammonium sulfate (AMS). The 35–
55% AMS pellet was resuspended in Buffer A (20 mM Tris, pH 8.0,
50 mM NaCl). Soluble protein was applied to a Mono Q anion
exchange column (GE Healthcare) equilibrated in Buffer A, and
protein was eluted with a linear gradient with 20 mM Tris, pH 8.0,
1 M NaCl. Peak fractions were further purified by gel filtration using
an S200 16/60 column (GE Healthcare) in 20 mM Tris, pH 8.0,
150 mM NaCl, and glycerol was added to 20% prior to storage at –
20 uC.
Mucinase assays. Human saliva (10%), bovine submaxillary mucin
(0.04%, BSM; Sigma) and porcine gastric mucin type II or III (0.04%,
PGM; Sigma) in PBS were treated with 2 mg enzyme or equivalent
volume PBS vehicle control overnight in a final volume of 100 mla t
room temperature. EDTA (50 mM) was used where indicated to
inhibit metalloprotease activity. Samples were separated by electro-
phoresis through 1% agarose with 0.1% SDS at 23 V overnight in
TAE buffer. Proteins were transferred to polyvinylidene difluoride
(Amersham) and probed with 1:10000 biotinylated wheatgerm
agglutinin (WGA; US Biological) followed by horseradish peroxidase
(HRP)-conjugated streptavidin (Bio-Rad), and detected by enhanced
chemiluminescence (Thermo Fisher). Collection of human saliva
samples was in accordance with a protocol approved by the University
of Wisconsin Institutional Review Board. For experiments with cell-
bound mucins, goblet-like LS174T cells (ATCC) were grown in Eagle’s
Minimum Essential Medium (Mediatech) with 10% fetal bovine
serum (Atlanta Biologicals). Confluent monolayers in 24-well plates
were treated with 5 mg enzyme for 3 h at 37 uC, 5% CO2. Cells were
lysed and samples analysed as above.
Protease assays. For MUC7 cleavage, 30 ml whole human saliva was
incubated with 2 mg enzyme or PBS vehicle control for 90 min at
37 uC. Samples were separated by SDS-PAGE, transferred to
nitrocellulose and probed with 1:1000 rabbit anti-MUC7 (kind gift
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The Netherlands) and anti-rabbit-HRP. For C1-INH cleavage, 1 mg
C1-INH (Comptech) was treated with 1 mg enzyme in a final volume
of 30 ml for 3 h at 37 uC. Samples were analysed as above using
1:2000 goat anti-C1-INH and anti-goat-HRP. For casein cleavage, 5
or 10 mg enzyme was assayed using the EnzChek green fluorescence
protease assay kit (Molecular Probes/Invitrogen), according to the
manufacturer’s instructions.
Flow cytometry. The human T-lymphocyte Jurkat cell line was
obtained from ATCC and maintained as per the supplier’s
instructions. Cells were suspended to 5610
5 ml
–1 in RPMI with
5% fetal bovine serum and treated with 1 mg enzyme in a final
volume of 500 ml for the indicated times at 37 uC, 5% CO2. Cells
were pelleted at 400 g for 5 min and blocked by addition of 0.05%
BSA (Sigma) in Dulbecco’s PBS with Ca
2+/Mg
2+. Samples were
stained with phycoerythrin-conjugated anti-CD43 (clone L10;
Invitrogen) and analysed by flow cytometry on an LSR II (Becton
Dickinson).
Attachment assays. The HEp-2 human epithelial-like cell line was
acquired from ATCC and maintained as per the supplier’s instruc-
tions. Confluent monolayers (5610
5) in 24-well tissue culture plates
were used for attachment experiments and washed twice before use.
Bacteria were grown to an OD600 of 0.2–0.3, tagA expression was
induced with 0.1% arabinose for 2 h, and bacteria were applied to
monolayers for 30 min at 37 uC, 5% CO2. Non-attached bacteria
were removed by three PBS washes, HEp-2 cells were lysed in 1%
Triton X-100, and recovered bacteria were enumerated by serial
dilution and plating on LB agar with ampicillin. Percentage
attachment was calculated as output c.f.u./input c.f.u.6100%.
Statistical analyses were performed using GraphPad Prism. For
immunofluorescence analysis, HEp-2 cells were grown to confluent
monolayers on Lab-Tek II chamber slides (Nalge Nunc International)
and incubated with V. cholerae as above for 30 min, followed by
washing to remove non-attached bacteria. Samples were fixed with
2% paraformaldehyde and permeabilized with 0.1% Triton X-100
(Sigma), stained with 1:5000 anti-TcpA antibody (a kind gift of V. J.
DiRita) followed by 1:200 Alexa-488 anti-rabbit IgG and 1:50 Alexa-
594 phalloidin, and mounted in ProLong Gold antifade reagent with
DAPI (Molecular Probes). Coverslips were imaged using a 6100 oil
immersion lens on a Zeiss Axioplan IIi epifluorescence microscope.
RESULTS
Identification of TagA as a SLiMe
We previously identified and characterized StcE, a secreted
protein of E. coli O157:H7, that has been identified as the
prototype memberoffamilyM66 withinthe MEROPS protease
database (http://merops.sanger.ac.uk; Rawlings et al., 2010).
Members of this family, which we refer to as the SLiMe
family, share a conserved ~300 aa metalloprotease domain
with a predicted zinc-dependent active site sequence of
HEXGHXXXGXGH. SLiMe family members are found in
several species of the Gammaproteobacteria in the families
Vibrionaceae, Enterobacteriaceae, Aeromonadaceae and
Shewanellaceae. BLAST analysis and CLUSTAL W alignment
confirmed that V. cholerae TagA (RefSeq NP_230468.1) is a
homologue of StcE. The two proteins share amino acid
sequences with 37% similarity throughout the total protein
and 41% identity within the central, 300 aa metalloprotease
domain. In addition to TagA, V. cholerae encodes another
SLiMe, TagA-related protein (TARP; RefSeq NP_232548.1),
on chromosome II. Vibrio vulnificus also encodes a TARP
homologue on chromosome II, but lacks a tagA gene on
chromosome I. Several other pathogenic and environmental
vibrios, including Vibrio parahaemolyticus and Vibrio fischeri,
do not encode any SLiMes. All currently sequenced V.
cholerae isolates encodeTARP, whereas onlythose possessing
the VPI encode TagA. Because there is evidence that TagA is
expressed during human infection (Bina et al., 2003), we
chose to focus our studies solely on the functions of this
SLiMe family member in V. cholerae.
TagA is a secreted, ToxR-regulated protein
The tagA gene has a ToxT-dependent promoter (Withey &
Dirita, 2005) and encodes a 981 aa polypeptide with a
predicted molecular mass of 115 kDa. TagA has a leader
peptidase II-dependent signal sequence, which predicts that
the N-terminal cysteine of the processed protein will be
lipidated. Following secretion across the inner membrane,
TagA may be secreted extracellularly by a type II secretion
system, similar to StcE or the lipoprotein pullulanase (d’Enfert
et al., 1987; Stathopoulos et al., 2000), or may be associated
with the outer membrane via the attached N-terminal lipid
moiety (Bos et al., 2007). We therefore examined TagA
expression and secretion in vitro under ToxR-inducing
conditions. A polyclonal antibody was produced to a peptide
within the N-terminal region of TagA. Immunoblot analysis
demonstrated that TagA was expressed by V. cholerae O395
under ToxR-inducing conditions and not in the ToxR null
mutant strain JJM43 (Fig. 1a). An isogenic TagA deletion
strain (DtagA) was created using allelic exchange and used to
confirm that theantibody specifically recognized TagA. Owing
to a cross-reactive band of a very similar size, samples were
electrophoresed until the 75 kDa marker was at the bottom of
the acrylamide gel in order to resolve TagA. Natively expressed
TagA was detectable in both the supernatant and cell pellet
fractions (Fig. 1b). Overexpression of TagA in V. cholerae (see
below)resulted inlargeamountsofTagA inthesupernatant,
further confirming that it is a secreted protein. The
possibility remains that TagA is both secreted and cell-
associated, and that some protein may bind back to the cell
surface via its lipid moiety.
TagA is a metal-dependent mucinase
Inordertoconductfunctionalproteaseassays,weattempted
to purify TagA. For unknown reasons, the protein was not
expressed well in numerousstrainsof E. coli, withor without
a variety of epitope tags. We were able to overexpress TagA
with arabinose induction from a tagA recombinant-based
pBAD24 vector plasmid in the V. cholerae O395 back-
ground. The majority of overexpressed, recombinant TagA
was present as a soluble form in the culture supernatant.
Ammonium sulfate precipitation of filtered supernatants,
followed by ion exchange and subsequent size exclusion
chromatography, yielded highly purified TagA protein (data
not shown).
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order to specifically cleave mucin-type glycoproteins. We
hypothesize that SLiMe family members share a similar
mucin-specific substrate profile. We therefore investigated
potential mucinase activity of TagA. Solutions of crude
purified BSM or PGM type II or III were treated with
TagA. StcE served as a positive control, and EDTA was
used to inhibit metalloprotease activity. Mucins were
separated by agarose gel electrophoresis and probed with
WGA, a lectin that recognizes the N-acetylglucosamine
sugar linkage common to many glycoproteins. Mucins run
as large, diffuse bands using this method as a result of their
heterogeneity in size and glycosylations. Mucin cleavage,
detected as clearance of these lectin-reactive bands, was
evident in TagA- and StcE-treated samples, and was
prevented by incubation with EDTA (Fig. 2a). In addition
to reconstituted crude animal mucin preparations, we
investigated cleavage of human-derived mucins ex vivo and
in vitro. TagA cleaved mucins present in human saliva (Fig.
2b) and mucins that were attached to the LS174T human
goblet-like cell line (Fig. 2c).
TagA is not a general protease
StcE uniquely cleaves proteins with mucin-type O-
glycosylations (Grys et al., 2006). With the demonstration
that TagA cleaved mucins, we sought to confirm that it did
not exhibit general proteolytic activity toward non-mucin
substrates. Gelatin zymography was performed with
purified TagA, using trypsin as a positive control for
proteolysis. Like StcE, TagA did not exhibit any proteolytic
activity toward gelatin (data not shown). Furthermore,
TagA did not cleave hide powder azure and casein, two
common substrates used for measuring proteolytic activity
(Fig. 2d and data not shown).
Enzymic activities of TagA and StcE are not
identical
Our data suggest that TagA is a metal-dependent protease
that shares a similar mucin substrate profile to StcE. We
sought to further delineate the specific substrate profile by
examining cleavage of CD43, MUC7 and C1-INH, known
substrates of StcE. The cleavage of these substrates may
contribute to the role of StcE in EHEC infection (Grys et al.,
2005; Lathem et al., 2002; Szabady et al., 2009). As a
negative control, we purified a version of TagA with a
single point mutation in the active site (E433D), a
mutation that was previously demonstrated to inactivate
StcE and other zinc metalloproteases (Lathem et al., 2002).
CD43 is a large anti-adhesive glycoprotein found on the
surface of immune cells. TagA cleaved CD43 from the
surface of Jurkat T cells and, similarly to StcE, degraded
the O-glycosylated extracellular domain (Fig. 3a).
Immunoblotting with an antibody to the CD43 N terminus
revealed that TagA cleaved CD43 with less apparent
efficiency than StcE (discussed further below). MUC7 is a
250 kDa glycoprotein found in human saliva. Saliva samples
were treated with TagA and probed with a MUC7-specific
antibody, demonstrating cleavage of MUC7 (Fig. 3b).
Cleavage of MUC7 and CD43 was not observed with the
TagA(E433D) mutant, confirming that this mutation
inactivated the protease active site.
Unlike StcE, TagA was unable to cleave purified C1-INH
(Fig. 3c). This finding indicates that despite sharing a
conserved metalloprotease domain, the substrate specifi-
cities of TagA and StcE are not identical. We examined
cleavage efficiency of TagA toward CD43, a substrate that it
shares with StcE. Intact Jurkat cells were treated with
similar amounts of TagA or StcE for various times, and
CD43 on the surface was detected by flow cytometry. StcE
cleaved nearly all of the CD43 on the surface after 30 min;
in fact, reduction of CD43 on the surface was evident after
5 min of protease treatment (Fig. 4a and data not shown).
In contrast, although TagA cleaved some CD43 after
30 min, substantial cleavage was not evident until 1–3 h,
and remained incomplete after 3 h (Fig. 4b). TagA(E433D)
served as a negative control and did not remove any CD43
from the cell surface (Fig. 4c). Our results indicate that
TagA is less efficient at cleaving CD43 than StcE and,
combined with the lack of cleavage of C1-INH, suggest that
sequence divergence between StcE and TagA might confer
differing substrate preferences despite a general similarity
in substrate type.
Fig. 1. TagA is secreted by V. cholerae in a ToxR-dependent
manner. (a) V. cholerae O395 and the isogenic ToxR null mutant
strain JJM43 were grown under ToxR-inducing conditions until
late-exponential phase. Cells were pelleted, supernatants pre-
cipitated with TCA, and samples were analysed by SDS-PAGE
followed by immunoblotting with a polyclonal antibody raised to an
N-terminal peptide of TagA. (b) Experiments were performed as
described for (a), comparing V. cholerae O395 wt with the DtagA
strain.
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could promote intestinal colonization. With the demon-
stration of TagA mucinase activity, we next evaluated its
contribution in an in vitro model of V. cholerae attachment
to human epithelial-like cells (HEp-2) that has been used
previously to identify V. cholerae adherence factors
(Sperandio et al., 1995). Wild-type V. cholerae O395 and
the isogenic DtagA mutant strain were allowed to attach to
HEp-2 monolayers, washed and the attached bacteria
enumerated. Of the input V. cholerae cells, 3–15% adhered
to the HEp-2 cells, consistent with previously reported
attachment figures in this model (Sperandio et al., 1995).
The loss of TagA expression had no significant effect on V.
cholerae attachment. However, overexpression of proteo-
lytically inactive TagA(E433D), but not TagA, resulted in a
significant 70% increase in attachment of V. cholerae to the
cultured epithelial cells (Fig. 5a). We did not observe any
qualitative differences in protein expression or bacterial
autoaggregation between the TagA and TagA(E433D)
overexpression strains. Immunofluorescence microscopy
confirmed the increased attachment of the TagA(E433D)
ovexpression strain (Fig. 5c). A possible explanation for the
differential attachment observed is that TagA normally
binds and cleaves an unidentified epithelial cell surface
protein, but in the absence of proteolysis there remains a
receptor–ligand interaction that results in increased
attachment by the TagA(E433D) overexpression strain.
To test this hypothesis, we pretreated HEp-2 cells with
purified active TagA. This treatment reduced the hyper-
attachment of the TagA(E433D) overexpression strain (Fig.
5b), suggesting that active TagA cleaved the binding
partner of the TagA(E433D) mutant protein and elimi-
nated this receptor–ligand interaction. The addition of
purified TagA had no effect on the attachment of V.
cholerae DtagA cells not overexpressing the TagA(E433D)
mutant. These assays were repeated in the mucus-
producing cell line LS174T with similar results (data not
shown). We were unable to identify binding partner(s) for
the TagA(E433D) mutant using immunoprecipitation and
mass spectrometry, possibly as a result of interference by
proteinglycosylationwith massspectrometricidentification.
DISCUSSION
We have demonstrated that TagA, a homologue of E. coli
O157:H7 StcE and a member of the SLiMe family, is
expressed and secreted by V.cholerae under ToxR-dependent
Fig. 2. Cleavage of mucins by TagA. (a) Crude purified BSM or
PGM type II and III (0.04% in PBS) were treated with 2 mg TagA
or StcE or buffer control overnight at room temperature. EDTA
(50 mM) was included as a negative control to inhibit metallopro-
tease activity where indicated. Samples were separated by
agarose gel electrophoresis, transferred to polyvinylidene difluo-
ride and probed with WGA. (b) Saliva (10%) was treated and
probed as described for (a). (c) Differentiated goblet-like LS174T
cells were treated with 5 mg enzyme with or without EDTA for 3 h
at 37 6C, 5% CO2. Cells were lysed, and samples were analysed
as described for (a).
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and PGM, and LS174T goblet cell surface mucin, but does
not digest C1-INH, hide azure powder, casein or gelatin.
Substrate cleavage is prevented by EDTA or by a single
glutamic acid to aspartic acid substitution in the consensus
metalloprotease active site. We have thus shown that TagA is
a metalloprotease similar to StcE, which cleaves specific
mucins but does not exhibit general proteolysis. TagA
activity stands in clear contrast to the classic V. cholerae
mucinase, HA/P. HA/P is a broad-spectrum protease that
cleaves numerous non-mucin substrates (Finkelstein et al.,
1983; Ha ¨se & Finkelstein, 1990). HA/P is also regulated by
quorum sensing through HapR and is repressed under
conditions that induce the ToxR virulence regulon (Zhu
etal.,2002),whereasTagAisactivatedbyToxR (Tayloretal.,
1987).
TagA is homologous to StcE, but exhibits a distinct
proteolytic activity and is therefore a unique member of the
StcE-like metalloprotease family. Aeromonas hydrophila
TagA is the only other SLiMe protein whose activity has
been characterized. This protein cleaves C1-INH to the
same-sized product as the StcE-cleaved product (Pillai
et al., 2006), whereas TagA failed to cleave C1-INH. TagA
Fig. 3. Comparisons of TagA and StcE substrate profiles. (a) Intact Jurkat cells (110
6) were treated with 1 mg TagA,
TagA(E433D), StcE or PBS control at 37 6C, 5% CO2 for 30 min. Samples were separated by SDS-PAGE and
immunoblotted (IB) for the CD43 extracellular or intracellular domain. (b) Human saliva was treated with control or 2 mg enzyme
at 37 6C for 90 min, separated by SDS-PAGE, and immunoblotted for MUC7. (c) Purified C1-INH (1 mg) was treated with
control or 1 mg enzyme at 37 6C for 3 h, separated by SDS-PAGE and immunoblotted for C1-INH. (d) Purified enzymes (5 or
10 mg ) were evaluated for cleavage of fluorescent BODIPY-FL casein substrate using the EnzChek protease assay kit. Data are
means±SEM of two experiments.
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CD43, a substrate that it shares with StcE. A. hydrophila
TagA and EHEC StcE share 68% sequence similarity, as
compared to 35% for V. cholerae TagA and StcE. This
suggests that divergent sequence elements of these proteins
might dictate specificity for different substrates.
Our results further suggest that the homologous members
of the SLiMe family are restricted to proteolytic cleavage of
substrates within the general class of mucin-like O-linked
glycoproteins. TagA did not cleave gelatin, which is non-
glycosylated, or a fluorogenic casein substrate, which has
non-mucin O-glycosylations. Previous research suggests
that StcE recognizes an extended random coil structure in
the protein backbone that is induced by dense O-glycan
attachments, a structure common to mucins and mucin-
like glycoproteins (L. Walters & others, unpublished data).
We have been unable to identify specific conserved amino
acid sequences or glycan linkages that confer recognition
and cleavage by StcE. If TagA also recognizes the extended
random coil structure, why does StcE cleave C1-INH and
TagA does not? We hypothesize that among SLiMe family
members with different enzymic efficiencies, their ability to
cleave may depend on the length and glycosylation density
of the mucin-like region within the substrate. C1-INH has
a relatively short mucin-like region that is cleaved by StcE
(Lathem et al., 2004), whereas nearly the entire 250 aa
extracellular domain of CD43 is O-glycosylated. The
intestinal mucins possess variable numbers of tandem O-
glycosylated repeats and can form polymers up to 1 MDa
in size (Thornton & Sheehan, 2004). It appears that the
more efficient StcE mucinase can cleave proteins such as
C1-INH with relatively short mucin-like regions, whereas
less efficient enzymes like TagA require more extensive
mucin-like regions. We have shown that StcE is more
efficient at cleaving MUC7 than C1-INH, supporting the
hypothesis that the size of the mucin region may contribute
to protease activity (Grys et al., 2006). The structural and
sequence determinants of enzyme efficiency and specificity
of the SLiMe proteins remain to be investigated.
Determination of crystal structures and synthesis of
recombinant chimeric enzymes could be useful tools to
investigate these questions.
Many of the bacteria that encode SLiMes cause disease in
mucin-rich environments such as the human intestine, or
fish skin in the case of A. hydrophila, and the SLiMe
mucinase activity may be useful in promoting bacterial
colonization and disease in their respective hosts (Austin
et al., 2005; Beaz Hidalgo et al., 2008; Thompson et al.,
Fig. 4. TagA and StcE exhibit differing cleavage efficiencies
toward CD43. Intact Jurkat cells (510
5) were treated with control
or 1 mg enzyme at 37 6C, 5% CO2 for 30 min (grey shading), 1 h
(solid line) or 3 h (dotted line) as indicated. The presence of the
CD43 extracellular domain on the cell surface was detected by
flow cytometry. (a) StcE, (b) TagA and (c) E433D. Data are from a
representative of three independent experiments.
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mouse peritonitis model (Pillai et al., 2006), and StcE
promotes the intimate attachment of E. coli O157:H7
required for human colonization (Grys et al., 2005). TagA
is co-expressed with known virulence factors of V. cholerae
and is expressed in vivo during human infection (Bina et al.,
2003). V. cholerae colonization of the human intestine
occurs in the context of a mucus layer. Although TCP is
thought to promote attachment by causing bacterial self-
aggregation, a direct receptor–ligand interaction with host
cells has not been demonstrated for V. cholerae.W e
hypothesized that TagA may contribute to V. cholerae
attachment by clearing the mucus layer because TagA
demonstrably cleaves crude mucin preparations and the
surface mucus of goblet-like intestinal cells. However, we
were unable to demonstrate in vitro a defect in attachment
by bacteria lacking tagA. The attachment of V. cholerae to
HEp-2 cells in culture may have insufficient sensitivity to
measure the effects of mucin cleavage in an in vivo setting,
a more dynamic environment accompanied by peristalsis
of the small intestine. Preliminary attachment experiments
with the mucus-producing LS174T cell line yielded similar
results, further suggesting that more complex assays might
be required to fully understand the role of TagA in vivo.
StcE does not affect overall adherence of E. coli O157:H7
to epithelial cells, but specifically increases the ability of
Fig. 5. Attachment of V. cholerae TagA mutants to HEp-2 cells. (a) Exponential-phase V. cholerae O395, DtagA or DtagA
complemented with pBAD24 encoding TagA (ptagA) or TagA(E433D) (pE433D) were incubated with HEp-2 monolayers for
30 min at 37 6C, 5% CO2. wt and DtagA contained pBAD24 alone as a control. Monolayers were washed and attached
bacteria were enumerated by serial dilution and plating. Percentage attachment was calculated as output c.f.u./input c.f.u.100.
Data are from a representative of at least three independent experiments, and are presented as means±SD (n53). Statistical
analysis was performed using GraphPad Prism and one-way ANOVA with the Bonferroni post test; ***, P,0.001. (b)
Experiments were performed as described for (a), except that HEp-2 monolayers were first treated with 10 mg purified TagA for
2 h and washed prior to adding bacteria. Data were analysed as above; **, P,0.01. (c) HEp-2 monolayers were grown on
coverslips and attachment assays were performed as described. Samples were fixed and stained for immunofluorescence with
rabbit anti-TcpA to stain V. cholerae, and with phalloidin to label HEp-2 actin.
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et al., 2005).
TagA may play a role in attachment not revealed by our
assay, or it may be important for other aspects of V.
cholerae colonization and disease. The observation that
overexpression of a non-proteolytic mutant of TagA leads
to a large increase in V. cholerae attachment suggests that
TagA can mediate an interaction with the host cell surface.
The location of the tagA gene within the VPI and the fact
that TagA is positively co-regulated with TCP and other
ToxR targets provide circumstantial evidence that TagA
may play a role in V. cholerae disease. The possibility
remains that TagA may act similarly to the HA/P mucinase
in promoting detachment of V. cholerae cells, therefore
aiding transmission to the environment. Alternatively,
TagA may modulate the immune response to V. cholerae by
interacting with CD43 or other immune cell surface
mucins, as we have recently demonstrated for StcE
(Szabady et al., 2009). Another possibility is that TagA
plays a role promoting survival and growth in the non-
human environment for this pathogen. Such a role is a
current area of investigation in our laboratory.
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